Myocardial Texture in Hypertrophic Cardiomyopathy

Journal of the American Society of Echocardiography

Volumn 20, Issue 11, 2007, Pages 1253-1259

  Losi, Maria Angela ^a   Betocchi, Sandro ^a   Chinali, Marcello ^a   Barbati, Giovanni ^a   D'Alessandro, Gianluigi ^a   Cacace, Alessandra ^a   Lombardi, Raffaella ^a   Contaldi, Carla ^a   de Simone, Giovanni ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PULMONARY VEIN;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 35649025720     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2007.03.023     Document Type: Article

References (34)

1. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology foundation task force on clinical expert consensus documents and the European Society of Cardiology committee for practice guidelines (committee to develop an expert consensus document on hypertrophic cardiomyopathy). J Am Coll Cardiol 42 (2003) 1687-1713
2. Marian A.J., and Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33 (2001) 655-670
3. Maron B.J., Bonow R.O., Cannon III R.O., Leon M.B., and Epstein S.E. Hypertrophic cardiomyopathy; interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316 (1987) 780-789
4. Wigle E.D., Rakowski H., Kimball B.P., and Williams W.G. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92 (1995) 1680-1692
5. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
6. McKenna W.J., and Behr E.R. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart 87 (2002) 169-176
7. Nagueh S.F., Chen S., Patel R., Tsybouleva N., Lutucuta S., Kopelen H.A., et al. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy [erratum appears in J Mol Cell Cardiol 2004;37:903]. J Mol Cell Cardiol 36 (2004) 663-673
8. Burlew B.S., and Weber K.T. Cardiac fibrosis as a cause of diastolic dysfunction. Herz 27 (2002) 92-98
9. Lombardi R., Betocchi S., Losi M.A., Tocchetti C.G., Aversa M., Miranda M., et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108 (2003) 1455-1460
10. Varnava A.M., Elliott P.M., Sharma S., McKenna W.J., and Davies M.J. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84 (2000) 476-482
11. Shirani J., Pick R., Roberts W.C., and Maron B.J. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35 (2000) 36-44
12. Di Bello V. Ultrasonic myocardial tissue characterization: a methodological review. Ital Heart J 2 (2001) 333-343
13. O'Donnell M., Mimbs J.W., and Miller J.G. The relationship between collagen and ultrasonic attenuation in myocardial tissue. J Acoust Soc Am 65 (1979) 512-517
14. Mimbs J.W., O'Donnell M., Bauwens D., Miller J.W., and Sobel B.E. The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts. Circ Res 47 (1980) 49-58
15. Hoyt R.H., Collins S.M., Skorton D.J., Eriksen E.E., and Conyers D. Assessment of fibrosis in infarcted human hearts by analysis of ultrasonic backscatter. Circulation 4 (1985) 740-744
16. Picano E., Pelosi G., Marzilli M., Lattanzi F., Benassi A., Landini L., et al. In vivo quantitatively ultrasonic evaluation of myocardial fibrosis in humans. Circulation 81 (1990) 58-64
17. Lythall D.A., Bishop J., Greembaum R.A., Ilsley C.J.D., Mitchell A.G., Gibson D.G., et al. Relationship between myocardial collagen and echo amplitude in non-fibrotic heart. Eur Heart J 14 (1993) 344-350
18. Hall C.S., Scott M.J., and Lanza G.M. The extracellular matrix is an important source of ultrasound backscatter from myocardium. J Acoust Soc Am 107 (2000) 612-619
19. Maceira A.M., Barba J., Beloqui O., and Diez J. Ultrasonic backscatter and diastolic function in hypertensive patients. Hypertension 40 (2002) 239-243
20. Kozakova M., Buralli S., Palombo C., Bernini G., Moretti A., Favilla S., et al. Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 41 (2003) 230-236
21. Nagueh S.F., Lakkis N.M., Middleton K.J., Spencer III W.H., Zoghbi W.A., and Quinones M.A. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 99 (1999) 254-261
22. Chinali M., Romano C., Rocco A., Galderisi M., Betocchi S., and De Simone G. Depth variation bias and interaction with gain setting in ultrasonic tissue characterization by integrated backscatter analysis. J Am Soc Echocardiogr 16 (2003) 54-60
23. Monserrat L., Elliott P.M., Gimeno J.R., Sharma S., Penas-Lado M., and McKenna W.J. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 42 (2003) 873-879
24. Briguori C., Betocchi S., Losi M.A., Manganelli F., Piscione F., Pace L., et al. Noninvasive evaluation of left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol 81 (1998) 180-187
25. Limongelli G., Pacileo G., Cerrato F., Verrengia M., Di Simone A., Severino S., et al. Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: noninvasive evidence of electrical and textural substrate for ventricular arrhythmias. J Am Soc Echocardiogr 16 (2003) 803-807
26. Wickline S.A., Thomas III L.J., Miller J.G., Sobel B.E., and Perez J.E. The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation 72 (1985) 183-192
27. Choundhury L., Mahrholdt H., Wagner A., Choi K.M., Elliot M.D., Klocke F.J., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
28. Vitale D.F., Bonow R.O., Calabro R., De Cristofaro M., Pacileo G., Caso P., et al. Myocardial ultrasonic tissue characterization in pediatric and adult patients with hypertrophic cardiomyopathy. Circulation 94 (1996) 2826-2830
29. Lattanzi F., Spirito P., Picano E., Mazzarisi A., Landini L., Distante A., et al. Quantitative assessment of ultrasonic myocardial reflectivity in hypertrophic cardiomyopathy. J Am Coll Cardiol 17 (1991) 1085-1090
30. Mizuno R., Fujimoto S., Yamaji K., Yutani C., Hashimoto T., and Nakamura S. Myocardial ultrasonic tissue characterization for estimating histological abnormalities in hypertrophic cardiomyopathy: comparison with endomyocardial biopsy findings. Cardiology 96 (2001) 16-23
31. Patel R., Nagueh S.F., Tsybouleva N., Abdellatif M., Lutucuta S., Kopelen H.A., et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 104 (2001) 317-324
32. Senthil V., Chen S.N., Tsybouleva N., Halder T., Nagueh S.F., Willerson J.T., et al. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res 97 (2005) 285-292
33. Appleton C.P., Galloway J.M., Gonzalez M.S., Gaballa M., and Basnight M.A. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease: additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol 22 (1993) 1972-1982
34. Kawara T., Derksen R., de Groot J.R., Coronel R., Tasseron S., Linnenbank A.C., et al. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 104 (2001) 3069-3075